GSK plcGSKNYSE
Loading
Revenue PerformanceStable
Percentile Rank93
3Y CAGR+2.9%
5Y CAGR+5.6%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+2.9%/yr
vs -1.2%/yr prior
5Y CAGR
+5.6%/yr
Consistent
Acceleration
+4.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
5 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $31.95B | +1.8% |
| 2024 | $31.38B | +3.5% |
| 2023 | $30.33B | +3.4% |
| 2022 | $29.32B | +18.7% |
| 2021 | $24.70B | +1.4% |
| 2020 | $24.35B | -27.8% |
| 2019 | $33.75B | +9.5% |
| 2018 | $30.82B | +2.1% |
| 2017 | $30.19B | +8.2% |
| 2016 | $27.89B | - |